ConMed Foresees Dramatic Virus-Related Declines in 2Q20

ConMed reported 1Q20 orthopedic revenue of USD $99.3 million, -12.5% vs. 1Q19. Sales in the U.S. declined the most, falling -18.2% compared to the year prior, while international sales declined -8.7%. COVID-19 impacted the company’s China sales in January before spreading to other Asian markets. By March, ConMed saw disruptions in Europe and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us